Updated on 2024/10/09

写真a

 
OKAZAKI Masaki
 
Organization
Graduate School of Medicine Program in Integrated Medicine Assistant Professor
Graduate School
Graduate School of Medicine
Undergraduate School
School of Medicine Department of Medicine
Title
Assistant Professor
External link

Degree 1

  1. Doctor of Medicine （ 2020.10   Nagoya University ） 

To the head of Degree.▲

Research Interests 1

  1. 血液透析　腎代替療法　血液浄化　慢性腎臓病

To the head of Research Interests.▲

Research Areas 1

  1. Life Science / Nephrology  / 血液透析

To the head of Research Areas.▲

Research History 3

  1. Nagoya University   Clinical research education   Assistant Professor

    2023.7

  2. University of California Irvine School of Medicine   Division of Nephrology, Hypertension and Kidney Transplantation   Assistant Specialist

    2021.6 - 2023.6

    　 More details

    Country：United States

  3. 名古屋大学大学院医学系研究科　腎臓内科

    2017.5 - 2021.5

To the head of Research History.▲

Education 2

  1. Nagoya University

    - 2020.3

  2. Kanazawa University

    2004.4 - 2010.3

To the head of Education.▲

Professional Memberships 3

  1. 日本腎臓学会

  2. 日本内科学会

  3. 日本透析医学会

To the head of Professional Memberships.▲

Committee Memberships 1

  1.   厚生労働科学研究費補助金難治性疾患等政策研究事業　難治性腎障害に関する調査研究班　ネフローゼ症候群ガイドラインワーキンググループ  

    2018 - 2020   

To the head of Committee Memberships.▲
 

Papers 18

  1. Residual Kidney Function and Cause-Specific Mortality Among Incident Hemodialysis Patients Reviewed International coauthorship

    Okazaki, M; Obi, Y; Fi, TS; Rhee, CM; Kovesdy, CP; Kalantar-Zadeh, K

    KIDNEY INTERNATIONAL REPORTS   Vol. 8 ( 10 ) page： 1989 - 2000   2023.10

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：Kidney International Reports  

    Introduction: The survival benefit of residual kidney function (RKF) in patients on hemodialysis is presumably due to enhanced fluid management and solute clearance. However, data are lacking on the association of renal urea clearance (CLurea) with specific causes of death. Methods: We conducted a longitudinal cohort study of 39,623 adults initiating thrice-weekly in-center hemodialysis from 2007 to 2011 and had data on renal CLurea and urine volume. Multivariable cause-specific proportional hazards model was used to examine the associations between baseline RKF and cause-specific mortality, including sudden cardiac death (SCD), non-SCD cardiovascular death (CVD), and non-CVD. Restricted cubic splines were fitted for change in RKF over 6 months after initiating hemodialysis. Results: Among 39,623 patients with data on baseline renal CLurea and urine volume, there was a significant trend toward a higher mortality risk across lower RKF levels, irrespective of cause of death in a case-mix adjustment model (Ptrend < 0.05). Adjustment for ultrafiltration rate (UFR) slightly attenuated the association between low renal CLurea and high cause-specific mortality, whereas adjustment for highest potassium did not have substantial effect. Among 12,169 patients with data on change in RKF, a 6-month decline in renal CLurea showed graded associations with SCD, non-SCD CVD, and non-CVD risk, whereas the graded associations between faster 6-month decline in urine output and higher death risk were clear only for SCD and non-CVD. Conclusion: Lower RKF and loss of RKF were associated with higher cause-specific mortality among patients initiating thrice-weekly in-center hemodialysis.

    DOI： 10.1016/j.ekir.2023.07.020

    Web of Science

    Scopus

    PubMed

  2. Impact of old age on the association between in-center extended-hours hemodialysis and mortality in patients on incident hemodialysis Reviewed

    Okazaki M, Inaguma D, Imaizumi T, Hishida M, Kurasawa S, Kubo Y, Kato S, Yasuda Y, Katsuno T, Kaneda F, Maruyama S.

    PLoS One   Vol. 15 ( 7 ) page： e0235900   2020.7

    　More details

    Authorship：Lead author   Language：English   Publishing type：Doctoral thesis  

    DOI： 10.1371/journal.pone.0235900.

  3. Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis

    Nishibori, N; Okazaki, M; Miura, Y; Hishida, M; Kurasawa, S; Imaizumi, T; Kato, N; Kosugi, T; Kuro-o, M; Kasuga, H; Kaneda, F; Maruyama, S

    CLINICAL KIDNEY JOURNAL   Vol. 17 ( 6 ) page： sfae121   2024.6

    　More details

    Language：English   Publisher：Clinical Kidney Journal  

    Background and hypothesis: Extended-hours haemodialysis (HD) is associated with better clinical outcomes than conventional HD. We investigated whether extended-hours HD and conventional HD have varying effects on blood levels of calciprotein particles (CPPs) and phosphorus, which have been identified as major pathogenic molecules for vascular calcification. Methods: Patients who underwent conventional or extended in-centre daytime HD between January and March 2020 were included. Plasma CPP levels, representing only secondary CPPs (CPP-II), were measured in pre-dialysis samples. Linear and non-linear associations between CPPs and serum phosphorus levels were examined across dialysis modalities. Results: A total of 382 participants (185 undergoing extended-hours HD and 197 undergoing conventional HD) were included in the analysis. The median age of participants was 71 years, 65% of the patients were men and the mean phosphorus level was 5.4 mg/dl. Plasma CPP (CPP-II) levels were lower in the extended-hours HD group than in the conventional HD group [40 018 (arbitrary units) AU versus 75 728 AU; P <. 01]. Multivariable linear regression analysis showed that extended-hours HD was associated with lower natural logarithmic plasma CPP (CPP-II) levels: -0.64 (95% confidence interval -0.74 to -0.55). A restricted cubic spline function indicated that extended-hours HD was associated with lower plasma CPP (CPP-II) levels across levels of serum phosphorus, with significant differences observed between groups, especially in hyperphosphataemic conditions (P for interaction <.01). Conclusions: The extended-hours HD group had lower CPP levels than the conventional HD group despite no significant differences in serum phosphorus levels, which may contribute to better clinical outcomes in patients on extended-hours HD.

    DOI： 10.1093/ckj/sfae121

    Web of Science

    Scopus

    PubMed

  4. Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis Reviewed

    Kurasawa S., Imaizumi T., Kondo T., Hishida M., Okazaki M., Nishibori N., Takeda Y., Kasuga H., Maruyama S.

    International Journal of Cardiology   Vol. 402   page： 131822   2024.5

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Background: The natural history of aortic stenosis (AS) progression, especially before severe AS development, is not well documented. We aimed to investigate the time course of peak aortic jet velocity (Vmax) and AS progression risk according to baseline Vmax, particularly whether there is a Vmax threshold. Methods: In a retrospective multicenter cohort study of patients on hemodialysis with aortic valve calcification, we investigated the time series of Vmax and the relationship between the baseline Vmax and progression to severe AS by analyzing longitudinal echocardiographic data. Results: Among 758 included patients (mean age, 71 years; 65% male), patients with Vmax <1.5, 1.5–1.9, 2.0–2.4, 2.5–2.9, and 3.0–3.9 m/s were 395 (52%), 216 (29%), 85 (11%), 39 (5.1%), and 23 (3.0%), respectively. The Vmax slope was gradual (mean 0.05–0.07 m/s/year) at Vmax <2 m/s, but steeper (mean 0.13–0.21 m/s/year) at Vmax ≥2 m/s. During a median 3.2-year follow-up, 52 (6.9%) patients developed severe AS. While patients with Vmax <2 m/s rarely developed severe AS, the risk of those with Vmax ≥2 m/s increased remarkably with an increasing baseline Vmax; the adjusted incidence rates in patients with Vmax <1.5, 1.5–1.9, 2.0–2.4, 2.5–2.9, and 3.0–3.9 m/s were 0.59, 0.57, 4.25, 13.8, and 56.1 per 100 person-years, respectively; the adjusted hazard ratio per 0.2 m/s increase in the baseline Vmax was 1.49 (95% confidence interval: 1.32–1.68) when Vmax ≥2 m/s. Conclusions: The risk of progression to severe AS increased with the baseline Vmax primarily at ≥2 m/s; a Vmax threshold of 2 m/s was observed.

    DOI： 10.1016/j.ijcard.2024.131822

    Web of Science

    Scopus

    PubMed

  5. Calciprotein particles and phosphorus in conventional and extended-hours hemodialysis

    Nishibori, N; Okazaki, M; Imaizumi, T; Miura, Y; Kuro-O, M; Kasuga, H; Kaneda, F; Maruyama, S

    NEPHROLOGY DIALYSIS TRANSPLANTATION   Vol. 39   page： I2538 - I2538   2024.5

    　More details

  6. Association between stopping renin-angiotensin system inhibitors immediately before hemodialysis initiation and subsequent cardiovascular events

    Nakamura, Y; Inaguma, D; Imaizumi, T; Kurasawa, S; Hishida, M; Okazaki, M; Fujishima, Y; Nishibori, N; Suzuki, K; Takeda, Y; Maruyama, S

    HYPERTENSION RESEARCH   Vol. 47 ( 5 ) page： 1372 - 1379   2024.3

    　More details

    Language：English   Publisher：Hypertension Research  

    It is controversial whether renin-angiotensin system inhibitors (RASIs) should be stopped in patients with advanced chronic kidney disease (CKD). Recently, it was reported that stopping RASIs in advanced CKD was associated with increased mortality and cardiovascular (CV) events; however, it remains unclear whether stopping RASIs before dialysis initiation affects clinical outcomes after dialysis, which this study aimed to evaluate. In this multicenter prospective cohort study in Japan, we included 717 patients (mean age, 67 years; 68% male) who had a nephrology care duration ≥90 days, initiated hemodialysis, and used RASIs 3 months before hemodialysis initiation. The multivariable adjusted Cox models were used to compare mortality and CV event risk between 650 (91%) patients who continued RASIs until hemodialysis initiation and 67 (9.3%) patients who stopped RASIs. During a median follow-up period of 3.5 years, 170 (24%) patients died and 228 (32%) experienced CV events. Compared with continuing RASIs, stopping RASIs was unassociated with mortality (adjusted hazard ratio [aHR]: 0.82; 95% confidence interval [CI]: 0.50–1.34) but was associated with higher CV events (aHR: 1.59; 95% CI: 1.06–2.38). Subgroup analyses showed that the risk of stopping RASIs for CV events was particularly high in patients aged <75 years, with a significant interaction between stopping RASIs and age. This study revealed that patients who stopped RASIs immediately before dialysis initiation were associated with subsequent higher CV events. Active screening for CV disease may be especially beneficial for these patients. (Figure presented.)

    DOI： 10.1038/s41440-024-01616-8

    Web of Science

    Scopus

    PubMed

  7. 特集 血液浄化法に応じた食と栄養 4.長時間血液透析(2)今日から実践可能な,透析患者の低栄養への根本的対策

    菱田 学, 岡崎 雅樹, 西堀 暢浩, 今泉 貴広, 金田 史香, 丸山 彰一

    臨床透析   Vol. 39 ( 12 ) page： 1397 - 1404   2023.11

    　More details

    Publisher：日本メディカルセンター  

    DOI： 10.19020/cd.0000002767

    CiNii Research

    researchmap

  8. Number of calcified aortic valve leaflets: natural history and prognostic value in patients undergoing haemodialysis

    Kurasawa, S; Okazaki, M; Imaizumi, T; Kondo, T; Hishida, M; Nishibori, N; Takeda, Y; Kasuga, H; Maruyama, S

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING   Vol. 24 ( 7 ) page： 909 - 920   2023.6

    　More details

    Language：English   Publisher：European Heart Journal Cardiovascular Imaging  

    Aims: Aortic valve calcification in aortic sclerosis, a precursor of aortic stenosis (AS), is not always present in all three leaflets; how calcification develops in each leaflet is unknown. We aimed to investigate the natural history of calcification development in each aortic valve leaflet and the prognostic value of the number of calcified leaflets. Methods and results: In a retrospective multicentre cohort study of patients undergoing haemodialysis without AS, we observed calcification development in each aortic valve leaflet using echocardiography. We investigated the association between the number of calcified leaflets and AS development and mortality using time-to-event analysis. Among the 1507 patients (mean age, 66 years; 66% male) included in the longitudinal echocardiography analysis, 709 (47%) had aortic sclerosis at baseline: one-leaflet calcified, 370 (52%); two-leaflet calcified, 215 (30%); and three-leaflet calcified, 124 (17%). The median time for one calcified leaflet increase was 3-4 years, and 251 (17%) patients developed AS during a median 3.2-year follow-up. The increased number of calcified aortic valve leaflets was associated with developing AS; compared with that of one-leaflet calcified, the adjusted hazard ratios (aHRs) [95% confidence intervals (CIs)] of two- and three-leaflet calcified were 2.12 (1.49-3.00) and 4.43 (3.01-6.52), respectively; the aHR (95% CI) per one calcified leaflet increase was 2.24 (1.96-2.55). It was also associated with all-cause mortality; the aHR (95% CI) per one calcified leaflet increase was 1.18 (1.08-1.27). Conclusion: The number of calcified aortic valve leaflets strongly predicted AS development and even mortality in patients undergoing haemodialysis, suggesting the usefulness of assessing calcification for each valve leaflet separately using echocardiography.

    DOI： 10.1093/ehjci/jead020

    Web of Science

    Scopus

    PubMed

  9. A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts Reviewed

    Minatoguchi S, Saito S, Furuhashi K, Sawa Y, Okazaki M, Shimamura Y, Kaihan AB, Hashimoto Y, Yasuda Y, Hara A, Mizutani Y, Ando R, Kato N, Ishimoto T, Tsuboi N, Esaki N, Matsuyama M, Shiraki Y, Kobayashi H, Asai N, Enomoto A, Maruyama S.

    Scientific Reports   Vol. 12 ( 1 ) page： 5389   2022.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1038/s41598-022-09331-5

  10. A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020 Reviewed

    Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, Kurita N, Sasaki S, Nishiwaki H, Koizumi M, Saito S, Nishibori N, Oe Y, Yoshida M, Miyaoka Y, Akiyama S, Itano Y, Okazaki M, Ozeki T, Ichikawa D, Oguchi H, Kohsaka S, Kosaka S, Kataoka Y, Shima H, Shirai S, Sugiyama K, Suzuki T, Son D, Tanaka T, Nango E, Niihata K, Nishijima Y, Nozu K, Hasegawa M, Miyata R, Yazawa M, Yamamoto Y, Yamamoto R, Shibagaki Y, Furuichi K, Okada H, Narita I; Committee of Clinical Practical Guideline for Nephrotic Syndrome 2020.

    Clinical and Experimental Nephrology   Vol. 25 ( 12 ) page： 1277 - 1285   2021.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1007/s10157-021-02098-5

  11. Refractory Hypotension Caused by Selenium Deficiency in a Patient on Peritoneal Dialysis Invited Reviewed

    Ryuge A, Kim H, Suzuki Y, Okazaki M, Kojima H, Saito S, Kato N, Ishimoto T, Kosugi T, Maruyama S, Mizuno M.

    Internal Medicine   Vol. 60 ( 15 ) page： 2461 - 2464   2021.8

    　More details

  12. All-cause and cardiovascular mortality in patients undergoing hemodialysis with aortic sclerosis and mild-to-moderate aortic stenosis: A cohort study Reviewed

    Kurasawa S, Hishida M, Imaizumi T, Okazaki M, Nishibori N, Kondo T, Kasuga H, Maruyama S.

    Atherosclerosis   Vol. 331   page： 12 - 19   2021.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  13. Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019 Reviewed

    Koshi E, Saito S, Okazaki M, Toyama Y, Ishimoto T, Kosugi T, Hiraiwa H, Jingushi N, Yamamoto T, Ozaki M, Goto Y, Numaguchi A, Miyagawa Y, Kato I, Tetsuka N, Yagi T, Maruyama S.

    CEN Case Reports   Vol. 10 ( 1 ) page： 126 - 131   2021.2

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1007/s13730-020-00534-1

  14. Additional prognostic value of toe-brachial index beyond ankle-brachial index in hemodialysis patients Reviewed International coauthorship

    Hishida M, Imaizumi T, Menez S, Okazaki M, Akiyama S, Kasuga H, Ishigami J, Maruyama S, Matsushita K.

    BMC Nephrology   Vol. 21 ( 1 ) page： 353   2020.8

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1186/s12882-020-01991-7

  15. Survival Benefit of Maintained or Increased Body Mass Index in Patients Undergoing Extended-Hours Hemodialysis Without Dietary Restrictions Reviewed

    Hishida M, Imaizumi T, Nishiyama T, Okazaki M, Kaihan AB, Kato S, Kubo Y, Ando M, Kaneda H, Maruyama S.

    Journal of Renal Nutrition   Vol. 30 ( 2 ) page： 154 - 162   2020.3

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1053/j.jrn.2019.06.002.

  16. Circulating levels of CD34+ cells predict long-term cardiovascular outcomes in patients on maintenance hemodialysis Reviewed

    Kaihan AB, Hishida M, Imaizumi T, Okazaki M, Kaihan AN, Katsuno T, Taguchi A, Yasuda Y, Tsuboi N, Kosugi T, Maruyama S.

    PLoS One   Vol. 14 ( 10 ) page： e0223390   2019.10

    　More details

    Language：English  

    DOI： 10.1371/journal.pone.0223390

  17. Unfavorable effects of history of volume overload and late referral to a nephrologist on mortality in patients initiating dialysis: a multicenter prospective cohort study in Japan Reviewed

    Okazaki M, Inaguma D, Imaizumi T, Kada A, Yaomura T, Tsuboi N, Maruyama S.

    BMC Nephrology   Vol. 19 ( 4 ) page： 65   2018.3

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1186/s12882-018-0859-8.

  18. A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathy Reviewed

    Okazaki M, Yaomura T, Tsuboi T, Mizuno S, Nakamura T, Hasegawa T, Katayama M, Nakamura H, Iida H, Saito T, Maruyama S, Matsuo S.

    CEN Case Reports   Vol. 4 ( 2 ) page： 174 - 179   2015.11

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1007/s13730-014-0162-x.

▼display all

To the head of Papers.▲

Books 1

  1. エビデンスに基づくネフローゼ症候群診療ガイドライン2020

    東京医学社  2020.8 

To the head of Books.▲

Presentations 7

  1. Effects of Eating Meals during Hemodialysis Treatment on Depressive Symptoms: The FrEDI Randomized Controlled Trial International conference

    Masaki Okazaki, Connie M Rhee, Yoko Narasaki, Jenny I Shen, Anuja Shah, Ramanath Dukkipati, Tiane Dai, Li-Li Tong, Sharon Adler, Joel D. Kopple, and Kamyar Kalantar-Zadeh

    ASN Kidney Week 2023  2023.11 

    　More details

    Event date： 2023.11

    Country：United States  

  2. Dietary Protein Intake and Coronary Artery Calcification Changes Over Time in a Prospective Hemodialysis Cohort International conference

    Masaki Okazaki, Yoko Narasaki, Connie M Rhee, Kamyar Kalantar-Zadeh

    ASN Kidney Week 2022  2022.11  American Society of Nephrology

    　More details

    Event date： 2022.11

    Country：United States  

  3. Residual Kidney Function and Sudden Cardiac Death Among Incident Hemodialysis Patients International conference

    Masaki Okazaki, Yoshitsugu Obi, Tariq Shafi, Connie M Rhee, Kamyar Kalantar-Zadeh

    ASN Kidney Week 2022  2022.11  American Society of Nephrology

    　More details

    Event date： 2022.11

    Country：United States  

  4. Extended-hours hemodialysis with liberalized diet is associated with reduced risk of non-cardiovascular mortality in elderly dialysis patients International conference

    Masaki Okazaki, Takahiro Imaizumi, Manabu Hishida, Shimon Kurasawa, Nobuhiro Nishibori, Yoko Kubo, Yoshinari Yasuda, Sawako Kato, Daijo Inaguma, Fumika Kaneda, Hiroshi Kaneda, Shoichi Maruyama

    The ISN World Congress of Nephrology 2021  2021.4 

    　More details

    Event date： 2021.4

    Country：Canada  

  5. Self-Reported Quality of Life on Vitality in Patients with Advanced Chronic Kidney Disease: The Nationwide Cohort of Reach-J Study International conference

    Masaki Okazaki, Takahiro Imaizumi, Shimon Kurasawa, Kazuyoshi Goto, Yuki Fujishima, Asaka Hachiya, Takaya Ozeki, Yoshinari Yasuda, Sawako Kato, Shoichi Maruyama, Hirokazu Okada, Ichiei Narita, Takashi Wada, Naoki Kashihara, Kunihiro Yamagata

    The 9th Asia Pacific Chapter Meeting of the International Society of Peritoneal Dialysis  2019.9 

    　More details

    Event date： 2019.9

    Country：Japan  

  6. Extended-Hours Hemodialysis on the Frail Elderly Patients with Impaired Nutritional Status could be Effective in Improve Survival and Major Adverse Cardiovascular Events International conference

    Masaki Okazaki, Daijo Inaguma, Takahiro Imaizumi, Shimon Kurasawa, Kazuyoshi Goto, Yuki Fujishima,Yusaku Hashimoto, Asaka Hachiya, Takaya Ozeki, Yoshinari Yasuda, Sawako Kato, Fumika Kaneda Shoichi Maruyama

    The 9th Asia Pacific Chapter Meeting of the International Society of Peritoneal Dialysis  2019.9 

    　More details

    Event date： 2019.9

    Country：Japan  

  7. In-center extended-hour hemodialysis can be effective in improving the mortality of elderly dialysis patients International conference

    Masaki Okazaki, Daijo Inaguma, Takahiro Imaizumi, Manabu Hishida, Takaya Ozeki, Yoko Kubo, Yoshinari Yasuda, Sawako Kato, Naotake Tsuboi, Hiroshi Kaneda, Shoichi Maruyama

    ASN Kidney Week 2018  2018.10  American Society of Nephrology

    　More details

    Event date： 2018.10

    Country：United States  

▼display all

To the head of Presentations.▲

Research Project for Joint Research, Competitive Funding, etc. 2

  1. ⼤規模データによる腎不全関連低栄養への新規治療開発

    2020 - 2021

    上原記念生命科学財団   ポストドクトラルフェローシップ  

    　 More details

    Authorship：Principal investigator  Grant type：Other

  2. 包括的腎代替療法レジストリー研究

    2018 - 2019

    公益財団法人愛知腎臓財団研究助成 

    　 More details

    Authorship：Principal investigator 

To the head of Research Project for Joint Research, Competitive Funding, etc..▲

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. 自由食＋長時間血液透析が末期腎不全における免疫学的変調を是正するメカニズムの解明

    Grant number：24K19128  2024.4 - 2027.3

    科学研究費助成事業  若手研究

    岡崎 雅樹

    　 More details

    Authorship：Principal investigator 

    Grant amount：\4680000 （ Direct Cost: \3600000 、 Indirect Cost：\1080000 ）

    血液透析を受けている人々の感染症死亡リスクは、一般住民と比べて約8倍高い。この問題の根源は、従来の血液透析法では除去が困難な尿毒素群の蓄積が、異常な免疫状態を引き起こし、結果として感染症に脆弱になるためと考えられている。
    我々はこれまで、優れた尿毒素の除去と穏やかな除水が可能な長時間血液透析に、自由食を組み合わせた治療戦略が、従来透析と比べて格段に生命予後に優れること、特に感染症リスクの改善に大きな利点がある可能性を明らかにした。
    本研究は、優れた生命予後をもたらす自由食＋長時間透析という治療戦略が、慢性腎臓病を患う人々の免疫系に恩恵をもたらすという仮説を証明することを主目的とする。

To the head of KAKENHI (Grants-in-Aid for Scientific Research).▲
 

Teaching Experience (On-campus) 3

  1. Clinical research education

    2024

  2. Clinical research education

    2024

  3. Clinical research education

    2023

To the head of Teaching Experience (On-campus).▲
 

Social Contribution 1

  1. 血液透析患者における心臓突然死リスクと残存腎機能との関連性

    Role(s)：Editer,　Informant,　Contribution

    名古屋大学研究成果発信サイト  2023.8

To the head of Social Contribution.▲

Academic Activities 2

  1. 高度医療人材養成拠点形成事業　東海臨床・基礎融合研究ジュニアスペシャリスト育成のためのOJTプログラム

    Role(s)：Planning, management, etc.

    文部科学省  2024

  2. 質の高い臨床教育・研究の確保事業　スペシャリストの継続的育成によるサステナブルな臨床教育・研究力の強化事業

    Role(s)：Planning, management, etc.

    文部科学省  2023 - 2025

To the head of Academic Activities.▲